188 related articles for article (PubMed ID: 32452582)
1. Novel benzo[b]xanthene derivatives: Bismuth(III) triflate-catalyzed one-pot synthesis, characterization, and acetylcholinesterase, glutathione S-transferase, and butyrylcholinesterase inhibitory properties.
Turhan K; Pektaş B; Türkan F; Tuğcu FT; Turgut Z; Taslimi P; Karaman HS; Gulcin I
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000030. PubMed ID: 32452582
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study.
Çelik F; Türkan F; Aras A; Atalar MN; Karaman HS; Ünver Y; Kahriman N
Bioorg Chem; 2021 Feb; 107():104606. PubMed ID: 33476865
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Spectroscopic Analysis, and in Vitro/in Silico Biological Studies of Novel Piperidine Derivatives Heterocyclic Schiff-Mannich Base Compounds.
Boy S; Aras A; Türkan F; Akyıldırım O; Beytur M; Sedef Karaman H; Manap S; Yüksek H
Chem Biodivers; 2021 Dec; 18(12):e2100433. PubMed ID: 34596972
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of phloroglucinol derivatives possessing α-glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity.
Burmaoglu S; Yilmaz AO; Taslimi P; Algul O; Kilic D; Gulcin I
Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29323749
[TBL] [Abstract][Full Text] [Related]
5. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
7. Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular docking studies.
Bursal E; Turkan F; Buldurun K; Turan N; Aras A; Çolak N; Murahari M; Yergeri MC
Biometals; 2021 Apr; 34(2):393-406. PubMed ID: 33528765
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, design, and assessment of novel morpholine-derived Mannich bases as multifunctional agents for the potential enzyme inhibitory properties including docking study.
Boy S; Türkan F; Beytur M; Aras A; Akyıldırım O; Karaman HS; Yüksek H
Bioorg Chem; 2021 Feb; 107():104524. PubMed ID: 33317836
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
[TBL] [Abstract][Full Text] [Related]
14. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
15. Novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes: Synthesis, characterization, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibitory properties.
Taslimi P; Osmanova S; Caglayan C; Turkan F; Sardarova S; Farzaliyev V; Sujayev A; Sadeghian N; Gulçin İ
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22191. PubMed ID: 29992664
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
18. Novel functionally substituted esters based on sodium diethyldithiocarbamate derivatives: Synthesis, characterization, biological activity and molecular docking studies.
Karimov A; Orujova A; Taslimi P; Sadeghian N; Mammadov B; Karaman HS; Farzaliyev V; Sujayev A; Tas R; Alwasel S; Gulçin İ
Bioorg Chem; 2020 Jun; 99():103762. PubMed ID: 32224335
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
20. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
